Organised by:
Observer Research Foundation (ORF)
Abstract:
Expanding affordable access to innovative drugs will play a central role in addressing current and future global health challenges. This is particularly critical for low- and middle-income economies as they look to reduce disease burdens through innovative medicines and strengthen healthcare delivery. Is there a policy framework that would both incentivize life sciences companies to continue risk-taking investments into the research of transformative cures--and make these cures available to patients who can least afford but most need access to them? This discussion will seek to brainstorm & rebuild on best practice policies--including the convergence of intellectual property rights, voluntary licensing and strengthening healthcare infrastructure.
Date: October 17, 2019
Time: 10:30 A.M.
Venue:
Nilgiri room,
The Oberoi,
Dr. Zakir Hussain Marg,
New Delhi 110003 (India)
Note:
RSVP: architlohani29@gmail.com
Location:
Observer Research Foundation (ORF)
Abstract:
Expanding affordable access to innovative drugs will play a central role in addressing current and future global health challenges. This is particularly critical for low- and middle-income economies as they look to reduce disease burdens through innovative medicines and strengthen healthcare delivery. Is there a policy framework that would both incentivize life sciences companies to continue risk-taking investments into the research of transformative cures--and make these cures available to patients who can least afford but most need access to them? This discussion will seek to brainstorm & rebuild on best practice policies--including the convergence of intellectual property rights, voluntary licensing and strengthening healthcare infrastructure.
Date: October 17, 2019
Time: 10:30 A.M.
Venue:
Nilgiri room,
The Oberoi,
Dr. Zakir Hussain Marg,
New Delhi 110003 (India)
Note:
RSVP: architlohani29@gmail.com
Location:
